Association between obesity and combination antiretroviral therapy (cART) adherence among persons with early-stage HIV infection initiating cART.


Journal

International journal of obesity (2005)
ISSN: 1476-5497
Titre abrégé: Int J Obes (Lond)
Pays: England
ID NLM: 101256108

Informations de publication

Date de publication:
08 2021
Historique:
received: 02 10 2020
accepted: 23 04 2021
revised: 23 03 2021
pubmed: 20 5 2021
medline: 29 1 2022
entrez: 19 5 2021
Statut: ppublish

Résumé

Obesity is common among people living with HIV (PLWH) and early-stage infection, yet associations with combination antiretroviral (cART) adherence are unclear. Among PLWH initiating cART in Uganda and South Africa, body mass index (BMI) was assessed at cART initiation, and cART adherence was monitored in real-time over 12 months. The association of obesity (BMI ≥ 30 kg/m Among 322 participants, median age was 32 years, 70% were female, and 54% were from Uganda. Prevalence of obesity was 12% in Uganda and 28% in South Africa. Mean overall cART adherence was 83% in Uganda and 66% in South Africa. Participants with obesity had higher adherence than those without obesity: +3.6% (p = 0.44) in Uganda and +11.4% (p = 0.02) in South Africa. Obesity at cART initiation was common and associated with higher adherence, although only significantly in South Africa.

Sections du résumé

BACKGROUND
Obesity is common among people living with HIV (PLWH) and early-stage infection, yet associations with combination antiretroviral (cART) adherence are unclear.
METHODS
Among PLWH initiating cART in Uganda and South Africa, body mass index (BMI) was assessed at cART initiation, and cART adherence was monitored in real-time over 12 months. The association of obesity (BMI ≥ 30 kg/m
RESULTS
Among 322 participants, median age was 32 years, 70% were female, and 54% were from Uganda. Prevalence of obesity was 12% in Uganda and 28% in South Africa. Mean overall cART adherence was 83% in Uganda and 66% in South Africa. Participants with obesity had higher adherence than those without obesity: +3.6% (p = 0.44) in Uganda and +11.4% (p = 0.02) in South Africa.
CONCLUSION
Obesity at cART initiation was common and associated with higher adherence, although only significantly in South Africa.

Identifiants

pubmed: 34007011
doi: 10.1038/s41366-021-00837-y
pii: 10.1038/s41366-021-00837-y
pmc: PMC8316269
mid: NIHMS1697167
doi:

Substances chimiques

Anti-Retroviral Agents 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1855-1859

Subventions

Organisme : NICHD NIH HHS
ID : K23 HD097300
Pays : United States
Organisme : NIMH NIH HHS
ID : K24 MH114732
Pays : United States
Organisme : NIDDK NIH HHS
ID : L30 DK118710
Pays : United States
Organisme : NIDDK NIH HHS
ID : P30 DK040561
Pays : United States

Investigateurs

Bosco M Bwana (BM)
Gideon Amanyire (G)
Lynn T Matthews (LT)
Alexander C Tsai (AC)
Ingrid T Katz (IT)
Kathleen Bell (K)
Annet Kembabazi (A)
Stephen Mugisha (S)
Victoria Kibirige (V)
Anna Cross (A)
Nicola Kelly (N)
Bethany Hedt-Gauthier (B)
David R Bangsberg (DR)

Informations de copyright

© 2021. The Author(s), under exclusive licence to Springer Nature Limited.

Références

Collaborators GBDO, Afshin A, Forouzanfar MH, Reitsma MB, Sur P, Estep K, et al. Health effects of overweight and obesity in 195 countries over 25 years. N Engl J Med. 2017;377:13–27.
doi: 10.1056/NEJMoa1614362
WHO. Global Health Observatory (GHO) data. https://www.who.int/data/gho/data/indicators/indicator-details/GHO/prevalence-ofoverweight-among-adults-bmi-=-25-(age-standardized-estimate)-(-) .
Guehi C, Badje A, Gabillard D, Ouattara E, Koule SO, Moh R, et al. High prevalence of being Overweight and Obese HIV-infected persons, before and after 24 months on early ART in the ANRS 12136 Temprano Trial. AIDS Res Ther. 2016;13:12.
doi: 10.1186/s12981-016-0094-y
WHO. HIV/AIDS. In: Key facts; 2019.
Coetzee L, Bogler L, De Neve JW, Barnighausen T, Geldsetzer P, Vollmer S. HIV, antiretroviral therapy and non-communicable diseases in sub-Saharan Africa: empirical evidence from 44 countries over the period 2000 to 2016. J Int AIDS Soc. 2019;22:e25364.
doi: 10.1002/jia2.25364
Biggs C, Spooner E. Obesity and HIV: a compounding problem. South Afr J Clin Nutr. 2018;31:78–83.
doi: 10.1080/16070658.2017.1404299
Bailin SS, Gabriel CL, Wanjalla CN, Koethe JR. Obesity and weight gain in persons with HIV. Curr HIV/AIDS Rep. 2020;17:138–150.
doi: 10.1007/s11904-020-00483-5
Venter WDF, Moorhouse M, Sokhela S, Fairlie L, Mashabane N, Masenya M, et al. Dolutegravir plus Two Different Prodrugs of Tenofovir to Treat HIV. N Engl J Med. 2019;381:803–815.
doi: 10.1056/NEJMoa1902824
Kumar S, Samaras K. The impact of weight gain during HIV treatment on risk of pre-diabetes, diabetes mellitus, cardiovascular disease, and mortality. Front Endocrinol. 2018;9:705.
doi: 10.3389/fendo.2018.00705
Haberer JE, Bwana BM, Orrell C, Asiimwe S, Amanyire G, Musinguzi N, et al. ART adherence and viral suppression are high among most non-pregnant individuals with early-stage, asymptomatic HIV infection: an observational study from Uganda and South Africa. J Int AIDS Soc. 2019;22:e25232.
doi: 10.1002/jia2.25232
Mayega RW, Etajak S, Rutebemberwa E, Tomson G, Kiguli J. ‘Change means sacrificing a good life’: perceptions about severity of type 2 diabetes and preventive lifestyles among people afflicted or at high risk of type 2 diabetes in Iganga Uganda. BMC Public Health. 2014;14:864.
doi: 10.1186/1471-2458-14-864
Lambert RF, Orrell C, Bangsberg DR, Haberer JE. Factors that motivated otherwise healthy HIV-positive young adults to access HIV testing and treatment in South Africa. AIDS Behav. 2018;22:733–741.
doi: 10.1007/s10461-017-1704-y
Zheng W, McLerran DF, Rolland B, Zhang X, Inoue M, Matsuo K, et al. Association between body-mass index and risk of death in more than 1 million Asians. N Engl J Med. 2011;364:719–729.
doi: 10.1056/NEJMoa1010679
Manne-Goehler J, Baisley K, Vandormael A, Bärnighausen T, Tanser F, Herbst K, et al. BMI and All-Cause Mortality in a Population-Based Cohort in Rural South Africa. Obesity. 2020;28:2414–23. https://doi.org/10.1002/oby.23005 .
doi: 10.1002/oby.23005 pubmed: 33070472
Heerden Iv. Mieliepap (maize meal porridge) and the glycaemic index. Health. 2013;24. https://www.health24.com/Diet-and-nutrition/Nutrition-basics/Mieliepap-maize-meal-porridge-and-the-glycaemic-index-20130210 .
Tsai AC, Bangsberg DR, Emenyonu N, Senkungu JK, Martin JN, Weiser SD. The social context of food insecurity among persons living with HIV/AIDS inrural Uganda. Soc Sci Med 2011,73:1717–24.
Bolton P, Wilk CM, Ndogoni L. Assessment of depression prevalence in rural Uganda using symptom and function criteria. Soc Psychiatry Psychiatr Epidemiol 2004,39:442–7.
Bradley KA, DeBenedetti AF, Volk RJ, Williams EC, Frank D, Kivlahan DR. AUDIT-C as a brief screen for alcohol misuse in primary care. Alcohol Clin Exp Res 2007,31:1208–17.
Jeyaseelan L, Kumar S, Mohanraj R, Rebekah G, Rao D, Manhart LE. Assessing HIV/AIDS stigma in south India: validation and abridgement of the Berger HIV Stigma scale. AIDS Behav 2013,17:434–43.

Auteurs

Nicholas Musinguzi (N)

Global Health Collaborative, Mbarara University of Science and Technology, Mbarara, Uganda. nmusinguzi@gmail.com.

Fatima Cody Stanford (FC)

Department of Medicine- Neuroendocrine Unit, Department of Pediatrics- Endocrine, Nutrition Obesity Research Center at Harvard (NORCH) Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.

Adeline A Boatin (AA)

Department of Obstetrics and Gynecology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.

Catherine Orrell (C)

Desmond Tutu HIV Centre, Department of Medicine & Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Observatory, Cape Town, South Africa.

Stephen Asiimwe (S)

Global Health Collaborative, Mbarara University of Science and Technology, Mbarara, Uganda.
Kabwohe Clinical Research Centre, Kabwohe, Uganda.

Mark Siedner (M)

Center for Global Health, Massachusetts General Hospital, Boston, MA, USA.
Department of Medicine, Harvard Medical School, Boston, MA, USA.
Africa Health Research Institute, KwaZulu-Natal, South Africa.

Jessica E Haberer (JE)

Center for Global Health, Massachusetts General Hospital, Boston, MA, USA.
Department of Medicine, Harvard Medical School, Boston, MA, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH